STEVARD, LLC – CRISPR Therapeutics AG Transaction History
STEVARD, LLC portfolio value:
$374,000
portfolio value
STEVARD, LLC quarter portfolio value change:
+4.11%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 15K | $65.35 | 5.71K | |
| Q1 2022 | share | Decrease | -14.49% | -969 shares | -148K | $62.77 | 5.71K |
| Q4 2021 | share | Decrease | -16.80% | -1.35K shares | -393K | $78.85 | 6.68K |
| Q3 2021 | share | Increase | +1.18% | 94 shares | -386K | $111.93 | 8.03K |
| Q2 2021 | share | Increase | +0.53% | 42 shares | 323K | $161.89 | 7.94K |
| Q1 2021 | share | Decrease | -7.10% | -604 shares | -339K | $121.85 | 7.90K |
| Q4 2020 | share | Decrease | -27.60% | -3.24K shares | 319K | $153.11 | 8.50K |
| Q3 2020 | share | Increase | +24.61% | 2.32K shares | 290K | $83.64 | 11.74K |
| Q2 2020 | share | Increase | 0.00% | 9.42K shares | 693K | $73.49 | 9.42K |